Open an account

iRhythm Holdings

IRTC · NASDAQ

$113.85+$4.25 (+3.88%)TodayMarket closed ·
Prev close $109.60

About IRTC

iRhythm Holdings, Inc. is a digital healthcare company, which engages in the provision of design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. The company is headquartered in San Francisco, California and currently employs 2,400 full-time employees. The company went IPO on 2016-10-20. The firm's principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. The firm provides Zio ambulatory cardiac monitoring services, including long-term continuous monitoring (LTCM), short-term continuous monitoring, and mobile cardiac telemetry (MCT) monitoring services, using a proprietary system that combines an FDA-cleared and CE-marked wire-free, patch-based, 14-day wearable biosensor that continuously records ECG data, with a proprietary FDA-cleared, CE-marked, Japan PDMA approved cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Employees
2,400
Headquarters
San Francisco, California
Listed
Oct 20, 2016
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
irhythmtech.com

IRTC key statistics

Market cap
3.75B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
499.79K
Volume
499.28K
Open price
$110.68
High today
$114.95
Low today
$110.68
52 Week high
$212.00
52 Week low
$100.70

iRhythm Holdings (IRTC) at a glance

As of Oct 20, 2026, iRhythm Holdings (IRTC) shares are priced at $113.85, giving the company a market cap of 3.75B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $110.68 and $114.95. The current price is 2.9% above the day's low and 1.0% below its high.

Volume so far is 499.28K shares, in line with the average of 499.79K shares a day.

Over the past year iRhythm Holdings has ranged from $100.70 to $212.00, and now sits 12% of the way up that range.

iRhythm Holdings met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.58 per share against an estimate of -$0.0045.

The average analyst price target is $179.76, 57.9% above the current price, from 15 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

93%of 15 analyst ratings say Buy
  • Buy93.3%
  • Hold6.7%
  • Sell0.0%
Price target · 16 analystsAvg $179.76
Low
$158.57
Now
$113.85
High
$205.80

IRTC earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 1999.3% on average.

  1. Q3 FY24: reported -$1.26 per share against an estimate of -$0.5842
  2. Q4 FY24: reported $0.01 per share against an estimate of -$0.2598
  3. Q1 FY25: reported -$0.95 per share against an estimate of -$0.9967
  4. Q2 FY25: reported -$0.32 per share against an estimate of -$0.4855
  5. Q3 FY25: reported -$0.06 per share against an estimate of -$0.3166
  6. Q4 FY25: reported $0.29 per share against an estimate of $0.0347
  7. Q1 FY26: reported -$0.35 per share against an estimate of -$0.662
  8. Q2 FY26: reported $0.58 per share against an estimate of -$0.0045

IRTC news

  • Press releasePRNewswire

    Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Press releaseGlobe Newswire

    iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026

  • Press releasePRNewswire

    Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Press releasePRNewswire

    Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm

  • Vandana Singh

    iRhythm Combines Strong Performance with VitalConnect Buy to Expand Remote Cardiac Care

  • Press releasePRNewswire

    Bernstein Litowitz Berger & Grossmann LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of iRhythm Technologies, Inc. Common Stock

  • Press releasePRNewswire

    Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Press releasePRNewswire

    Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Similar companies

Companies in the same industry as iRhythm Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.